TL;DR
Get the little things that make your day delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A report reviewing research on menopause-related sleep problems ranks cognitive behavioral therapy for insomnia (CBT-I) first, regular exercise second and supplements a distant third. A trial in midlife women found CBT-I improved insomnia symptoms, while evidence for melatonin and valerian was uncertain or weak. Sleep problems can have different causes, so the report says treatment should match the pattern.
A LifeHack report reviewing research on menopause-related sleep problems ranks cognitive behavioral therapy for insomnia (CBT-I) as the best-supported non-drug option, followed by regular exercise, with supplements well behind. The ranking matters because waking during the night can have different causes, and evidence for popular products such as melatonin and valerian is limited or uncertain.
The report’s strongest treatment evidence comes from a randomized trial of 106 midlife women who had frequent hot flashes and insomnia. At eight weeks, participants receiving telephone-delivered CBT-I had insomnia severity scores about 5.2 points lower than participants receiving menopause education; the improvement remained at 24 weeks. That finding applies to the women in the trial and does not mean CBT-I will work the same way for every person.
CBT-I is a structured treatment, not simply general sleep advice. It often involves working with a clinician, therapist or guided digital program on sleep schedules, time spent in bed and responses to being awake at night. The American College of Physicians recommends CBT-I as the initial treatment for adults with chronic insomnia, based on moderate-quality evidence. That guideline is for adults generally, while the trial cited by the report is more directly relevant to midlife women with hot flashes.
The report places regular exercise second, but supplies no comparable effect size in the source material. It ranks supplements lower: pooled results from four randomized trials in menopausal women did not show a statistically significant effect of melatonin on sleep quality. A 2024 umbrella review of eight systematic reviews found the evidence for valerian weak or inconclusive, with no evidence of efficacy for insomnia. Those findings mean benefits are not established; they do not prove that no individual could benefit.
Why Treatment Depends on the Wake-Up Pattern
The report argues that menopause-related sleep disruption is not a single problem with a single remedy. It groups common patterns into heat-related waking, possible physical causes such as disordered breathing, and learned wakefulness that can persist after hot flashes ease. This is the report’s organizing framework, not a formal clinical classification, and more than one pattern can occur in the same person.
The distinction matters because a supplement aimed at sleep quality may not address repeated hot-flash-related waking or an unrecognized breathing disorder. In a study of 168 midlife women monitored with actigraphy, 78% of objectively recorded nocturnal hot flashes coincided with a wake episode. The report cautions that coincidence does not prove every awakening was caused by a flash, but the finding supports a connection between the two.
Persistent sleep loss can affect daytime functioning as well as nights. The source describes fatigue, low mood and difficulty concentrating as consequences people may experience. Its central practical point is to avoid treating every disrupted night as evidence that a supplement has failed—or that the person has done something wrong—before considering what may be driving the waking.
How Menopause Sleep Disruption Was Measured
The report draws on the Study of Women’s Health Across the Nation, which enrolled 3,045 women ages 42 to 52 and followed them through the menopausal transition. The study found that the odds of both trouble falling asleep and trouble staying asleep rose across that transition.
A secondary analysis covering ten years reported self-described insomnia symptoms at least three times a week in 31% of women in early perimenopause in the first year, rising to 39% by year ten. Among women in late perimenopause, the figures were 32% and 48%, respectively. These are reported symptoms, not diagnoses of insomnia, and the figures vary by menopausal stage and year.
Other evidence cited in the report points to issues that can be missed when sleep complaints are attributed only to hot flashes. In the Sleep in Midlife Women Study, the adjusted apnea-hypopnea index—a measure of breathing events—was about 31% higher after menopause than before it. That is not a measure of new sleep apnea diagnoses. The report notes that obstructive sleep apnea in women may present with insomnia, fatigue or low mood rather than the snoring people often associate with the condition.
“CBT-I is recommended as the initial treatment for all adults with chronic insomnia.”
— American College of Physicians, as cited in the report
Limits in the Remedy Evidence
The report’s ordering is an evidence-based interpretation, not the result of a head-to-head trial comparing CBT-I, exercise and supplements. The source material gives a clear trial result for CBT-I but does not provide equivalent effect estimates for exercise, so the size of its benefit relative to other options cannot be established from the information provided.
For melatonin, a result that was not statistically significant is uncertain evidence, not proof of no effect. The valerian review similarly describes weak or inconclusive evidence. The available findings do not establish which product, dose or duration might help a particular person, nor do they show that supplements address every cause of nighttime waking.
The source material also begins a discussion of American Academy of Sleep Medicine guidance but cuts off before giving the full recommendation. It therefore does not support a complete account of that guidance. The report’s three-pattern framework is presented as an organizing tool, not a diagnosis; readers should not use it to identify sleep apnea or another condition on their own.
Discuss Persistent Waking With a Clinician
The report does not announce a new clinical guideline or a change in treatment recommendations. Its practical next step is to identify whether sleep trouble is mainly associated with hot flashes, another physical symptom, or wakefulness that continues even when flashes are less prominent, and to discuss persistent problems with a health professional.
For ongoing insomnia, readers can ask about CBT-I and whether a clinician-led, therapist-led or guided digital program is available. When sleep disruption includes significant fatigue, low mood or symptoms that raise concern about breathing during sleep, a clinician can assess whether further evaluation is appropriate. The source material does not specify a new study or policy milestone; the evidence cited reflects research already published.
Key Questions
The report ranks CBT-I first. A randomized trial in 106 midlife women with frequent hot flashes and insomnia found improved insomnia severity compared with menopause education, with gains still present at 24 weeks.
Does the evidence show that melatonin does not work?
No. The pooled effect on sleep quality across four randomized trials in menopausal women was not statistically significant. That makes the evidence uncertain; it does not prove melatonin cannot help any individual.
What does the report say about valerian?
A 2024 umbrella review covering eight systematic reviews judged the evidence for valerian weak or inconclusive and found no evidence of efficacy for insomnia. The report does not establish a reliable benefit.
Can hot flashes explain every nighttime awakening?
No. In one study, 78% of objectively recorded nocturnal hot flashes coincided with a wake episode, but that does not show that every awakening begins with a hot flash. The report also discusses breathing-related and learned waking patterns.
When should someone seek medical advice about disrupted sleep?
Consider discussing persistent sleep problems with a health professional, particularly if they are affecting daytime life or come with fatigue, low mood or possible breathing symptoms. A clinician can assess possible causes and discuss treatment options such as CBT-I.
Source: rss
Products Worth Considering
CBT-I digital sleep therapy program
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
